13FHALOZYME THERAPEUTICS INC (HALO)
5 tracked managers currently hold HALO on their latest filing. Change is versus that manager’s previous filing. Reported as of quarter end, filed up to ~45 days later, not live positions.
Sort: Size Weight change
Sorted by reported value on the latest filing.
| Manager | Period | Change | Value | Weight | Prev weight | Shares | Δ shares |
|---|---|---|---|---|---|---|---|
| D. E. Shaw & Co., Inc. | Q2 2026 | ADD | $157.0M | 0.1 % | 0.1 % | 2,006,479 | +137,771 |
| TWO SIGMA INVESTMENTS, LP | Q2 2026 | ADD | $129.4M | 0.1 % | 0.1 % | 1,653,285 | +68,324 |
| Bridgewater Associates, LP | Q2 2026 | TRIM | $36.3M | 0.1 % | 0.1 % | 463,146 | -48,283 |
| CITADEL ADVISORS LLC | Q2 2026 | ADD | $22.6M | 0.0 % | 0.0 % | 289,090 | +98,039 |
| MILLENNIUM MANAGEMENT LLC | Q2 2026 | TRIM | $1.6M | 0.0 % | 0.0 % | 19,858 | -451,426 |